Antiretroviral Clinical Pharmacology: Playing the Long Game, presented by Dr. Aaron Devanathan, PharmD, PhD

Please join us Tuesday, February 13th at 4pm ET for an exciting lecture on the clinical pharmacology of antiretrovirals by Dr. Aaron Devanathan, PharmD, PhD, leader of the Certara Academic Center of Excellence program at Pitt Pharmacy.

The Sex and Gender Scientific Working Group of the Rustbelt Center for AIDS Research is excited to invite you to a presentation by one of our Rustbelt Center for AIDS Research 2023 Developmental Grant Awardees:
Dr. Aaron Devanathan, PharmD, PhD
Assistant Professor
“Antiretroviral Clinical Pharmacology: Playing the Long Game”
4PM ET on Tuesday, February 13, 2024

Please click on the link below to register:
https://teams.microsoft.com/registration/Ptc9i3JOeUaxkVbaFYhxKw,o520upVoDkeB_mAS4Wdy6Q,N-DJAiZN2U6cPn_kCWlsPg,r7EtxqUTQk2bJRvZGEuu3Q,SSeRmx0EGkebNFnZWVd6OA,q5bZ0CfyUEamO79NyzO5Mg?mode=read&tenantId=8b3dd73e-4e72-4679-b191-56da1588712b

Dr. Aaron Devanathan is an Assistant Professor in the Department of Pharmacy and Therapeutics at the University of Pittsburgh School of Pharmacy. He received his PharmD from the University of Pittsburgh and completed his PGY1 Pharmacy Practice Residency at UNC Hospitals. He earned a PhD in Pharmaceutical Sciences and completed the UNC-Duke Collaborative Clinical Pharmacology T32 Postdoctoral Training Program at the UNC Eshelman School of Pharmacy before returning as faculty at the University of Pittsburgh in 2022. His research focuses on the clinical pharmacology of antiretrovirals and their disposition into biological matrices with the goal of understanding how antiretroviral pharmacology affects inflammatory processes related to HIV-associated comorbidities.

Dr. Devanathan’s CFAR Development Grant focuses on developing analytical methods to quantify antiretroviral concentrations for PrEP and his methods are currently being developed for use in vaginal and cervical tissues.